RARECast

548 Episoder

1. Treating Huntington's Disease by Addressing Neuroinflammation

   Publisert: 24.6.2020
2. How Patient Advocate-Led Research Can Alter a Rare Disease Landscape

   Publisert: 17.6.2020
3. Keeping Clinical Trials Going During a Pandemic

   Publisert: 10.6.2020
4. Looking for Commonalities in Rare

   Publisert: 3.6.2020
5. Learning to Be Comfortable Being Uncomfortable

   Publisert: 27.5.2020
6. An Approach to De-Risk Rare Disease Drug Development

   Publisert: 20.5.2020
7. Targeting Epigenetics in Rare Proliferative Bone Marrow Cancers

   Publisert: 13.5.2020
8. Chiesi Charges Ahead in Rare Disease

   Publisert: 6.5.2020
9. Targeting the Metabolism of Rare Cancers

   Publisert: 29.4.2020
10. Unlocking Bryson's Brain

    Publisert: 22.4.2020
11. Living Therapies for Chronic Conditions

    Publisert: 15.4.2020
12. A One-to-Many Approach to Gene Therapy for Retinal Disease

    Publisert: 8.4.2020
13. Targeting an Immune Switch in Rare Diseases

    Publisert: 1.4.2020
14. Targeting the Regulatory Genome to Treat Rare Blood Diseases

    Publisert: 25.3.2020
15. A Reborn Forma Therapeutics Focuses on Rare Blood Diseases and Cancer

    Publisert: 18.3.2020
16. Targeting Genetic Diseases at Their Root Cause

    Publisert: 11.3.2020
17. Targeting Hormone Dysregulation in Prader-Willi Syndrome

    Publisert: 4.3.2020
18. Rare Disease Advocates Take to the Hill

    Publisert: 25.2.2020
19. Targeting a Common Link in Otherwise Different Rare Diseases

    Publisert: 19.2.2020
20. Bringing Clinical Trials to Patients

    Publisert: 12.2.2020